These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 820194

  • 1. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR, Frölich JC, Bowden RE, Taylor AA, Keiser HR, Seyberth HW, Oates JA, Bartter FC.
    Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE, Gill JR, Radfar N, Taylor AA, Keiser HR.
    JAMA; 1978 Jan 09; 239(2):117-21. PubMed ID: 412983
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome.
    Bartter FC, Gill JR, Frolich JC, Bowden RE, Hollifield JW, Radfar N, Keiser HR, Oates JA, Seyberth H, Taylor AA.
    Trans Assoc Am Physicians; 1976 Jan 09; 89():77-91. PubMed ID: 828345
    [Abstract] [Full Text] [Related]

  • 4. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I, Hesse B, Christensen P.
    Acta Med Scand Suppl; 1979 Jan 09; 625():135-40. PubMed ID: 285569
    [Abstract] [Full Text] [Related]

  • 5. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A.
    Nephrologie; 1980 Jan 09; 1(3):113-6. PubMed ID: 6945487
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandins and aspirin therapy in Bartter's syndrome.
    Norby L, Flamenbaum W, Lentz R, Ramwell P.
    Lancet; 1976 Sep 18; 2(7986):604-6. PubMed ID: 61344
    [Abstract] [Full Text] [Related]

  • 7. [Increased renal prostaglandin E2 secretion in Bartter's syndrome].
    Schwarz HA, Weidmann P, Messerli FH, Zia PK, Flammer J, Reubi RC.
    Schweiz Med Wochenschr; 1977 Dec 10; 107(49):1870-2. PubMed ID: 929154
    [Abstract] [Full Text] [Related]

  • 8. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH, Hewitt GJ, Mitchell MD.
    Int J Pediatr Nephrol; 1984 Mar 10; 5(1):31-8. PubMed ID: 6370882
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome.
    Hsieh BS, Chen WY, Yen TS, Lai MS.
    Taiwan Yi Xue Hui Za Zhi; 1978 Nov 10; 77(11):831-8. PubMed ID: 284093
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of Bartter's syndrome with indomethacin.
    Garin EH, Fennell RS, Iravani A, Richard GA.
    Am J Dis Child; 1980 Mar 10; 134(3):258-61. PubMed ID: 6767392
    [Abstract] [Full Text] [Related]

  • 11. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H, Kawasaki T, Okumura M, Asano T, Abe K, Arakawa K.
    Endocrinol Jpn; 1980 Aug 10; 27(4):417-29. PubMed ID: 7007031
    [No Abstract] [Full Text] [Related]

  • 12. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A, Mantero F, Opocher G, Armanini D, Lechi C, Covi G.
    J Endocrinol Invest; 1981 Aug 10; 4(1):17-20. PubMed ID: 7016967
    [Abstract] [Full Text] [Related]

  • 13. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A, Chaimovitz C, Levi Y, Benderli A, Better OS.
    Pediatr Res; 1980 Dec 10; 14(12):1395-7. PubMed ID: 7010289
    [Abstract] [Full Text] [Related]

  • 14. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L, Glasson P, Flory ED, Dray F, Vallotton MB.
    Schweiz Med Wochenschr; 1979 Feb 03; 109(5):142-7. PubMed ID: 441720
    [Abstract] [Full Text] [Related]

  • 15. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ, de Jong PE, van Eps LW, Brentjens JR, Bakker K, Doorenbos H.
    Nephron; 1977 Feb 03; 19(4):200-13. PubMed ID: 917167
    [Abstract] [Full Text] [Related]

  • 16. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM, Gill JR, Bowden RE, Pisano JJ, Izzo JL, Radfar N, Taylor AA, Zusman RM, Bartter FC, Keiser HR.
    J Clin Invest; 1978 Jun 03; 61(6):1671-82. PubMed ID: 96139
    [Abstract] [Full Text] [Related]

  • 17. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP, Telfer N, Zia P, Speckart P, Golub M, Rude R.
    Am J Med; 1976 May 31; 60(6):785-97. PubMed ID: 798488
    [Abstract] [Full Text] [Related]

  • 18. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G, Margolius HS.
    Ann Intern Med; 1977 Sep 31; 87(3):281-6. PubMed ID: 900671
    [Abstract] [Full Text] [Related]

  • 19. Hypokalemia and prostaglandin overproduction in Bartter's syndrome.
    Senba S, Konishi K, Saruta T, Ozawa Y, Kato E, Amagasaki Y, Nakata I.
    Nephron; 1984 Sep 31; 37(4):257-63. PubMed ID: 6379486
    [Abstract] [Full Text] [Related]

  • 20. The role of chloride transport in the thick ascending limb in the pathogenesis of Bartter's syndrome.
    Gill JR.
    Klin Wochenschr; 1982 Oct 01; 60(19):1212-4. PubMed ID: 6755050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.